Existing studies suggest that T cells CD4+ can target tumor cells in direct or indirect ways, either by eliminating tumor cells through the complex mechanisms, including the regulation of the tumor immune microenvironment, affecting antigen presentation, co-stimulation, and T cell homing [39, 40]. Here, CD4 is linked to neoplasm.